Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.
OBJECTIVES: To evaluate international pediatric efavirenz dosing recommendations using full pharmacokinetic (PK) information. DESIGN: Open-label, multicenter, PK study. METHODS: Forty-one HIV-infected Ugandan children (3-12 years) on efavirenz + lamivudine + abacavir were enrolled in a study of twi...
Main Authors: | Fillekes, Q, Natukunda, E, Balungi, J, Kendall, L, Bwakura-Dangarembizi, M, Keishanyu, R, Ferrier, A, Lutakome, J, Gibb, D, Burger, D, Walker, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.
by: Fillekes, Q, et al.
Published: (2014) -
The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.
by: Musiime, V, et al.
Published: (2014) -
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
by: Bienczak, A, et al.
Published: (2016) -
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
by: Fillekes, Q, et al.
Published: (2012) -
Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial
by: Schomaker, M, et al.
Published: (2024)